Publicaciones en colaboración con investigadores/as de Instituto de Salud Carlos III (5)

2020

  1. Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness

    Molecular Cancer, Vol. 19, Núm. 1

2019

  1. New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools

    Journal of Experimental and Clinical Cancer Research, Vol. 38, Núm. 1

2018

  1. NAMPT is a potent oncogene in colon cancer progression that modulates cancer stem cell properties and resistance to therapy through sirt1 and PARP

    Clinical Cancer Research, Vol. 24, Núm. 5, pp. 1202-1215

2017

  1. Inflammation and stem markers association to PIM1/PIM2 kinase-induced tumors in breast and uterus

    Oncotarget, Vol. 8, Núm. 35, pp. 58872-58886

  2. NAMPT overexpression induces cancer stemness and defines a novel tumor signature for glioma prognosis

    Oncotarget, Vol. 8, Núm. 59, pp. 99514-99530